Maven Securities LTD Intra Cellular Therapies, Inc. Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $383,517 - $585,443	-8,919 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $345,522 - $553,780	8,919 New	8,919 $546,000
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $146,472 - $216,699	-5,100 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $149,430 - $226,950	5,100 New	5,100 $209,000
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $564,933 - $724,692	-18,342 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$23.34 - $32.22 $428,102 - $590,979	18,342 New	18,342 $591,000

377

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.88B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.